Cost-effectiveness study on influenza prevention in Hong Kong. (Q30328288)

18 June 2017

title

Cost-effectiveness study on influenza prevention in Hong Kong. (English)

1 reference

cost-effectiveness analysis

18 June 2017

main subject

1 reference

Fitzner KA

1

1 reference

18 June 2017

Shortridge KF

series ordinal

2

1 reference

18 June 2017

McGhee SM

series ordinal

3

1 reference

18 June 2017

Hedley AJ

series ordinal

4

1 reference

18 June 2017

publication date

1 June 2001

1 reference

18 June 2017

1 reference

18 June 2017

volume

56

1 reference

18 June 2017

issue

3

1 reference

18 June 2017

page(s)

215-234

1 reference

Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.

18 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Influenza vaccination in 18 developed countries, 1980-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

The effectiveness of vaccination against influenza in healthy, working adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Estimating country-specific cost-effectiveness from multinational clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

The next pandemic influenza virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

The next influenza pandemic: lessons from Hong Kong, 1997

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Rapid virological surveillance of community influenza infection in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

Impact of respiratory virus infections on persons with chronic underlying conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900140-8

7 January 2021

10.1016/S0168-8510(00)00140-8

Identifiers

DOI

1 reference

18 June 2017

1 reference